Literature DB >> 3252304

Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus.

S Loizou1, M A Byron, H J Englert, J David, G R Hughes, M J Walport.   

Abstract

The presence of anticardiolipin antibodies has been associated with the occurrence of spontaneous abortions in patients with systemic lupus erythematosus. Retrospective analysis of the relationship between the levels of IgG and IgM anticardiolipin antibodies in 84 patients with SLE and the prevalence of spontaneous abortions was performed. The time at which abortion occurred amongst these patients was compared with that in 26 subjects with a poor obstetric history, but without SLE. Forty-six of 84 patients had anticardiolipin antibodies and had 143 pregnancies, of which 84 (58.7 per cent) resulted in fetal loss. In contrast, amongst the 38 patients without anticardiolipin antibodies only 23 of 93 pregnancies (24.7 per cent) resulted in fetal loss. The prevalence of spontaneous abortions in the SLE patients was related to the levels of IgG anticardiolipin antibodies; IgM anticardiolipin antibodies were not associated with increased fetal loss. In SLE patients without anticardiolipin antibodies, and in the group of patients without SLE, fetal loss occurred at 14.1 +/- 7.5 (mean +/- SD) and 12.5 +/- 5.5 weeks respectively. When anticardiolipin antibodies were present fetal loss tended to occur at a later stage of pregnancy (17.4 +/- 7.1 weeks) and amongst this group 30 per cent of the pregnancy losses were in the third trimester of pregnancy. These findings demonstrate further that anticardiolipin antibodies are strongly linked to late pregnancy failure in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3252304

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  10 in total

Review 1.  Pregnancy and antibodies to phospholipids.

Authors:  M J Walport
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

Review 2.  Pregnancy in systemic lupus erythematosus.

Authors:  C C Mok; R W Wong
Journal:  Postgrad Med J       Date:  2001-03       Impact factor: 2.401

Review 3.  The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.

Authors:  J S Cameron; G Frampton
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

4.  Active disease during pregnancy is associated with poor foetal outcome in Indian patients with systemic lupus erythematosus.

Authors:  Vinod Chandran; Amita Aggarwal; Ramnath Misra
Journal:  Rheumatol Int       Date:  2004-12-31       Impact factor: 2.631

Review 5.  Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome.

Authors:  Guillermina Girardi
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

6.  Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders.

Authors:  S Loizou; C Cofiner; A P Weetman; M J Walport
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

7.  Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group.

Authors:  C Sachse; K Lüthke; K Hartung; M Fricke; B Liedvogel; J R Kalden; H H Peter; H J Lakomek; E Henkel; H Deicher
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 8.  Preconception care: screening and management of chronic disease and promoting psychological health.

Authors:  Zohra S Lassi; Ayesha M Imam; Sohni V Dean; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

9.  Ciprofloxacin-Induced Reaction Imitating a Lupus Flare: A Case Report.

Authors:  Adnan Liaqat; Aisha Barlas; Talal Barlas; Hamna Khurram; Hamza Liaqat
Journal:  Cureus       Date:  2020-05-28

10.  Recurrent fetal loss and antiphospholipid antibodies: clinical and therapeutic aspects.

Authors:  O Blétry; A M Piette
Journal:  Infect Dis Obstet Gynecol       Date:  1997
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.